Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

32.7K
Overview
32.7K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

76
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
76
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

2.0K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.0K
Antibody Structure01:10

Antibody Structure

66.2K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
66.2K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

1.3K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.3K
Allergic Drug Reactions01:27

Allergic Drug Reactions

1.5K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Teclistamab in Elderly Patients With Relapsed/Refractory Multiple Myeloma: A Subgroup Analysis of the French RetrosTECtive Cohort.

EJHaem·2026
Same author

Dual-energy computed tomography (CT) versus cone-beam computed tomography (CT) in chronic thromboembolic pulmonary hypertension: diagnostic accuracy compared with digital subtraction angiography.

Clinical radiology·2025
Same author

Journal white-list versus special issues.

European annals of otorhinolaryngology, head and neck diseases·2025
Same author

Indication for biologics in a real-world cohort of dupilumab treated chronic rhinosinusitis with nasal polyps patients according to international recommendations: evidence from the European CRS Outcome Registry (CHRINOSOR).

Rhinology·2025
Same author

Overabundant populations of large wild herbivores disrupt plant-pollinator networks in a Mediterranean ecosystem.

Plant biology (Stuttgart, Germany)·2025
Same author

Effects of combining cold exposure and compression on muscle recovery: a randomized crossover study.

Frontiers in physiology·2025
Same journal

Assessment of morbidity and mortality in emergency tracheotomy in head-and-neck cancer patients under palliative care.

European annals of otorhinolaryngology, head and neck diseases·2026
Same journal

Necrotizing toxic laryngitis following combined polysubstance smoking of crack cocaine and heroin.

European annals of otorhinolaryngology, head and neck diseases·2026
Same journal

French-language adaptation and linguistic validation of the ETDQ-7 Eustachian tube dysfunction assessment questionnaire following COSMIN guidelines.

European annals of otorhinolaryngology, head and neck diseases·2026
Same journal

Prognostic impact of invasion patterns and circumferential spread of internal carotid artery on survival in patients with nasopharyngeal carcinoma.

European annals of otorhinolaryngology, head and neck diseases·2026
Same journal

Palatine tonsil metastasis from small cell lung cancer.

European annals of otorhinolaryngology, head and neck diseases·2026
Same journal

Impact of great auricular nerve preservation status post parotidectomy on quality of life.

European annals of otorhinolaryngology, head and neck diseases·2026
See all related articles

Related Experiment Video

Updated: Feb 27, 2026

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
06:08

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

2.7K

Specific immunotherapy in allergic rhinitis.

G Mortuaire1, J Michel2, J F Papon3

  • 1Inserm U995, service d'ORL et de chirurgie cervicofaciale, Lille Inflammation Research International Center, université de Lille, hôpital Huriez, CHU de Lille, 59000 Lille, France.

European Annals of Otorhinolaryngology, Head and Neck Diseases
|July 8, 2017
PubMed
Summary
This summary is machine-generated.

Allergen-specific immunotherapy (SIT) effectively reduces allergic rhinitis symptoms and medication needs. This treatment can prevent asthma development and new allergies, offering a safe and effective option for patients.

Keywords:
AllergyAsthmaImmunotherapyRhinitis

More Related Videos

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

1.6K
A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
06:34

A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma

Published on: June 4, 2017

10.5K

Related Experiment Videos

Last Updated: Feb 27, 2026

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
06:08

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

2.7K
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

1.6K
A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
06:34

A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma

Published on: June 4, 2017

10.5K

Area of Science:

  • Immunology
  • Otolaryngology
  • Allergology

Background:

  • Allergic rhinitis significantly impacts quality of life.
  • Allergen-specific immunotherapy (SIT) is the only treatment that can alter the disease course.
  • SIT is underutilized by the ENT community despite its benefits.

Purpose of the Study:

  • To review the efficacy of SIT in allergic rhinitis.
  • To highlight the benefits of SIT for symptom control and disease progression.
  • To discuss the role of SIT for ENT practitioners.

Main Methods:

  • Review of recent meta-analyses and clinical studies on SIT.
  • Analysis of immunobiological changes associated with SIT.
  • Comparison of sublingual SIT (drops and tablets) with subcutaneous SIT.

Main Results:

  • SIT significantly reduces allergic rhinitis symptoms and medication requirements.
  • SIT lowers the risk of developing asthma and new sensitizations.
  • Sublingual SIT (drops and tablets) is as effective as subcutaneous SIT with a better safety profile.

Conclusions:

  • SIT is a valuable treatment for allergic rhinitis, offering symptom relief and disease modification.
  • Sublingual SIT presents a practical and safe option for wider adoption by ENT specialists.
  • Standardization of clinical trials is recommended for further comparative studies.